These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 29603404

  • 1. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis.
    Brück J, Dringen R, Amasuno A, Pau-Charles I, Ghoreschi K.
    Exp Dermatol; 2018 Jun; 27(6):611-624. PubMed ID: 29603404
    [Abstract] [Full Text] [Related]

  • 2. The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects.
    Mrowietz U, Morrison PJ, Suhrkamp I, Kumanova M, Clement B.
    Trends Pharmacol Sci; 2018 Jan; 39(1):1-12. PubMed ID: 29183628
    [Abstract] [Full Text] [Related]

  • 3. Fumaric acid esters.
    Rostami Yazdi M, Mrowietz U.
    Clin Dermatol; 2008 Jan; 26(5):522-6. PubMed ID: 18755371
    [Abstract] [Full Text] [Related]

  • 4. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M, Ammal Kaidery N, Yang L, Calingasan N, Smirnova N, Gaisin A, Gaisina IN, Gazaryan I, Hushpulian DM, Kaddour-Djebbar I, Bollag WB, Morgan JC, Ratan RR, Starkov AA, Beal MF, Thomas B.
    J Neurosci; 2016 Jun 08; 36(23):6332-51. PubMed ID: 27277809
    [Abstract] [Full Text] [Related]

  • 5. Dimethylfumarate for psoriasis: more than a dietary curiosity.
    Mrowietz U, Asadullah K.
    Trends Mol Med; 2005 Jan 08; 11(1):43-8. PubMed ID: 15649822
    [Abstract] [Full Text] [Related]

  • 6. In vitro pharmacokinetics of anti-psoriatic fumaric acid esters.
    Litjens NH, van Strijen E, van Gulpen C, Mattie H, van Dissel JT, Thio HB, Nibbering PH.
    BMC Pharmacol; 2004 Oct 12; 4():22. PubMed ID: 15479475
    [Abstract] [Full Text] [Related]

  • 7. The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis.
    Tahvili S, Zandieh B, Amirghofran Z.
    Int J Dermatol; 2015 Jul 12; 54(7):e254-60. PubMed ID: 26108267
    [Abstract] [Full Text] [Related]

  • 8. Dimethyl- and monomethylfumarate regulate indoleamine 2,3-dioxygenase (IDO) activity in human immune cells.
    Eminel S, Jin N, Rostami M, Dibbert S, Mrowietz U, Suhrkamp I.
    Exp Dermatol; 2017 Aug 12; 26(8):685-690. PubMed ID: 27376248
    [Abstract] [Full Text] [Related]

  • 9. Pro-oxidant status and Nrf2 levels in psoriasis vulgaris skin tissues and dimethyl fumarate-treated HaCaT cells.
    Lee YJ, Bae JH, Kang SG, Cho SW, Chun DI, Nam SM, Kim CH, Nam HS, Lee SH, Lee SH, Cho MK.
    Arch Pharm Res; 2017 Sep 12; 40(9):1105-1116. PubMed ID: 28918452
    [Abstract] [Full Text] [Related]

  • 10. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
    Oehrl S, Olaru F, Kunze A, Maas M, Pezer S, Schmitz M, Schäkel K.
    J Dermatol Sci; 2017 Sep 12; 87(3):278-284. PubMed ID: 28732748
    [Abstract] [Full Text] [Related]

  • 11. No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P-glycoprotein (P-gp) drug transporter.
    Aubets J, Jansat JM, Salva M, Birks VM, Cole RJ, Lewis J, Pitcher A, Hall M.
    Pharmacol Res Perspect; 2019 Dec 12; 7(6):e00540. PubMed ID: 31832203
    [Abstract] [Full Text] [Related]

  • 12. Intracellular signalling by binding sites for the antipsoriatic agent monomethylfumarate on human granulocytes.
    Nibbering PH, Thio B, Bezemer AC, Beijersbergen RL, Zomerdijk TP.
    Br J Dermatol; 1997 Jul 12; 137(1):65-75. PubMed ID: 9274627
    [Abstract] [Full Text] [Related]

  • 13. Dimethylfumarate induces apoptosis in human mast cells.
    Förster A, Preussner LM, Seeger JM, Rabenhorst A, Kashkar H, Mrowietz U, Hartmann K.
    Exp Dermatol; 2013 Nov 12; 22(11):719-24. PubMed ID: 24112621
    [Abstract] [Full Text] [Related]

  • 14. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells.
    Stoof TJ, Flier J, Sampat S, Nieboer C, Tensen CP, Boorsma DM.
    Br J Dermatol; 2001 Jun 12; 144(6):1114-20. PubMed ID: 11422029
    [Abstract] [Full Text] [Related]

  • 15. Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein beta in activated human T cells.
    Gerdes S, Shakery K, Mrowietz U.
    Br J Dermatol; 2007 May 12; 156(5):838-42. PubMed ID: 17381463
    [Abstract] [Full Text] [Related]

  • 16. Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
    Lin-Holderer J, Li L, Gruneberg D, Marti HH, Kunze R.
    Neuropharmacology; 2016 Jun 12; 105():228-240. PubMed ID: 26801077
    [Abstract] [Full Text] [Related]

  • 17. Dimethyl fumarate modulates neutrophil extracellular trap formation in a glutathione- and superoxide-dependent manner.
    Hoffmann JHO, Schaekel K, Hartl D, Enk AH, Hadaschik EN.
    Br J Dermatol; 2018 Jan 12; 178(1):207-214. PubMed ID: 28733990
    [Abstract] [Full Text] [Related]

  • 18. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
    Landeck L, Asadullah K, Amasuno A, Pau-Charles I, Mrowietz U.
    Arch Dermatol Res; 2018 Aug 12; 310(6):475-483. PubMed ID: 29574575
    [Abstract] [Full Text] [Related]

  • 19. Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
    Loewe R, Pillinger M, de Martin R, Mrowietz U, Gröger M, Holnthoner W, Wolff K, Wiegrebe W, Jirovsky D, Petzelbauer P.
    J Invest Dermatol; 2001 Dec 12; 117(6):1363-8. PubMed ID: 11886496
    [Abstract] [Full Text] [Related]

  • 20. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
    Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, Ellrichmann G, Brück W, Dawson K, Goelz S, Wiese S, Scannevin RH, Lukashev M, Gold R.
    Brain; 2011 Mar 12; 134(Pt 3):678-92. PubMed ID: 21354971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.